Cancer services

Health and Social Care Committee Closed Inquiry
Opened: 6 Jul 2021 Closed: 1 Aug 2022 Parliament page
This inquiry will ask why cancer outcomes in England continue to lag behind comparable countries internationally and examine evidence relating to the underlying causes of these differences. We will also consider what impact disruption to cancer services during the covid-19 pandemic will have on efforts to catch up, and ask … Read more
15 Recommendations
15 Conclusions
1 Report
5 Oral sessions
3 Letters
5 Events
Activity timeline 15 events
5 Apr
2022
20 Jan
2022
20 Jan
2022
Formal meeting (oral evidence session) · The Grimond Room, Portcullis House
9 Nov
2021
9 Nov
2021
Formal meeting (oral evidence session) · Room 8, Palace of Westminster
26 Oct
2021
26 Oct
2021
Formal meeting (oral evidence session) · Room 5, Palace of Westminster
14 Sep
2021
Oral evidence sessions 5 sessions
Dame Cally Palmer · NHS England Judith Neptial, cancer patient Maria Caulfield · Department of Health and Social Care Mark Foulkes · Royal Berkshire NHS Foundation Trust Professor Peter Johnson · NHS England William Vineall · Department of Health and Social Care
Anna Jewell · Less Survivable Cancers Taskforce Ian Vousden · Kent and Medway Cancer Alliance Jane Lyons · Cancer52 Katy Hall, Expert by experience Professor David Baldwin · School of Medicine (University of Nottingham) Professor David Shackley · Greater Manchester Cancer Sarah Stevens · National Disease Registration Service, NHS Digital
Baroness Delyth Morgan · Breast Cancer Now David Watson · The Association of the British Pharmaceutical Industry (ABPI) Dr Philippa Hetherington, Expert by experience Professor David Cunningham · Association of Cancer Physicians Professor Mike Griffin · Royal College of Surgeons of Edinburgh Professor Nick James · Institute of Cancer Research Professor Pat Price · Action Radiotherapy
Andrea Brady, person with lived experience Dr Andrew Millar · North Central London Cancer Alliance Dr Jeanette Dickson · Council of the Academy of Medical Royal Colleges Dr Richard Roope · Royal College of General Practitioners Michelle Mitchell · Cancer Research UK Professor Peter Sasieni · King's College London, Clinical Trials Unit Sir Harpal Kumar · GRAIL Europe
Dame Cally Palmer · NHS England John Butler · International Cancer Benchmarking Partnership Prof Jon Emery · University of Melbourne Prof Peter Johnson · NHS England Prof Sir Mike Richards, Former National Cancer Director
Title HC No. Published Items Response
Twelfth Report - Cancer services HC 551 5 Apr 2022 30 Responded
Recommendations & Conclusions
4 results
19 Conclusion Deferred
Twelfth Report - Cancer services
Major specialist cancer hospitals have better access to staff, expertise and technology, and patients referred...
Major specialist cancer hospitals have better access to staff, expertise and technology, and patients referred to these sites are more likely to be offered potentially life- saving surgery. During the pandemic, these hospitals were the ones most likely to be … Read more
Government Response
The government's response states the Cancer Call for Evidence has closed, and the responses are being analysed alongside wider evidence for a new vision for cancer care in their 10-Year Cancer Plan.
Department of Health and Social Care
View details
20 Recommendation Deferred
Twelfth Report - Cancer services
As part of the Government’s new cancer plan, the Government and NHS England should review...
As part of the Government’s new cancer plan, the Government and NHS England should review the organisation of cancer surgery with a specific focus on whether more specialist hospitals should be established to ensure that more cancer surgery is carried … Read more
Government Response
The government deferred action, stating that the Cancer Call for Evidence is being analysed and the 10-Year Cancer Plan will address the organisation of cancer surgery.
Department of Health and Social Care
View details
26 Conclusion Deferred
Twelfth Report - Cancer services
There are specific challenges facing people with rare and less common and less survivable cancers,...
There are specific challenges facing people with rare and less common and less survivable cancers, including that they are often harder to diagnose and that issues with spreading best practice for treating less common cancers are more pronounced. Despite some … Read more
Government Response
The government is analysing responses to the Cancer Call for Evidence to develop the 10 Year Cancer Plan, which will address all cancer types, including rare and less survivable cancers.
Department of Health and Social Care
View details
27 Recommendation Deferred
Twelfth Report - Cancer services
The Government must consider rare, less common and less survivable cancers specifically as part of...
The Government must consider rare, less common and less survivable cancers specifically as part of its new cancer plan. NHS England should also produce an action plan for rare, less common and less survivable cancers, containing clear commitments to address … Read more
Government Response
The government deferred action, stating that it is analysing responses to the Cancer Call for Evidence and that the 10 Year Cancer Plan will address all cancer types, including rare and less survivable cancers.
Department of Health and Social Care
View details
Government Response AI assessment · 30 of 15 classified

Total 15 recs + 15 conclusions
Correspondence 3 letters
29 Mar 2022 Corresondence from the National Cancer Director on the Cancer services inquiry
Parliament page
25 Jan 2022 To committee Letter from the National Cancer Director and National Clinical Director on Cancer services dated 17.01.22
Parliament page
19 Oct 2021 To committee Letter from Jeanette Dickson providing further information requested by the Committee on Cancer services dated 28.09.21
Parliament page